Who owns BIOAFFINITY TECHNOLOGIES INC?
- Ticker: BIAF
- CUSIP Number: 09076w307
Tip: Access positions for across all investors
Analyze quarterly positions in Bioaffinity Technologies with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Bioaffinity Technologies stock
Who bought or sold BIOAFFINITY TECHNOLOGIES INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Capital Management | 56k | $213k | 100% | Mar 2026 |
|
| Geode Capital Management | 48k | $185k | 59% | Mar 2026 |
|
| J. Safra Sarasin Holding | 43k | $164k | 100% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 31k | $119k | 100% | Mar 2026 |
|
| Schonfeld Strategic Advisors | 24k | $94k | 100% | Mar 2026 |
|
| Northern Trust | 13k | $15k | 100% | Dec 2025 |
|
| UBS Group | 9.2k | $35k | 100% | Mar 2026 |
|
| Tower Research Capital | 3.9k | $4.6k | 56% | Dec 2025 |
|
| Ameritas Advisory Services | 1.0k | $3.8k | 100% | Mar 2026 |
|
| IFP Advisors | 833.00 | $3.2k | 0% | Mar 2026 |
|
| Citigroup | 57.00 | $218.002200 | 100% | Mar 2026 |
|
| Morgan Stanley | 3.00 | $11.000100 | 0% | Mar 2026 |
|
| Caitong International Asset Management | 1.00 | $4.000000 | 100% | Mar 2026 |
|
Who sold out of Bioaffinity Technologies?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Sabby Management | Sep 2025 | 243k | $719k |
| Citadel Advisors | Dec 2025 | 12k | $14k |
| Two Sigma Securities | Dec 2025 | 11k | $13k |
| Vanguard Group | Sep 2025 | 10k | $31k |
| Hanson McClain Advisors | Sep 2025 | 1.8k | $5.3k |
| Larson Financial Group | Sep 2025 | 33.00 | $98.000100 |
| FMR | Sep 2025 | 26.00 | $76.999000 |